4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-25-030284
Chief Executive Officer gave up 2,646 shares (to pay taxes)
- Chief Executive Officer acquired 8,726 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Robinson Chandler Chief Executive Officer | 2025-09-30 | Option exercise | +8,726 | 82,198 | D | ||
| Robinson Chandler Chief Executive Officer | 2025-09-30 | Shares withheld for taxes | −2,646 | $81.67 | $216,099 | 79,552 | D |
| Derivatives | |||||||
| Robinson Chandler Chief Executive Officer | 2025-09-30 | Option exercise · Restricted Stock Units | −8,726 | 72,599 | D | ||
Loading xslF345X05/rdgdoc.xml…